Newsroom

DALLAS--(BUSINESS WIRE)--Sonida Senior Living, Inc. (“Sonida” or the “Company”) (NYSE: SNDA), a leading owner, operator and investor in communities and services for seniors, announced today that it will issue its first quarter 2026 earnings results before the market opens for trading on Monday, May 11, 2026. The Company will then host a conference call and webcast to review its financial performance and operating results at 11:00 a.m. Eastern Time. The dial-in number for the conference call is...

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer and inflammatory and autoimmune diseases, today announced that the Compensation Committee of the Company’s Board of Directors granted one new employee options to purchase a total of 4,200 shares of the Company’s common stock at an exercise price per share of $25.13, which was the...

PONTIAC, Mich.--(BUSINESS WIRE)--UWM Holdings Corporation (NYSE:UWMC), the publicly traded indirect parent of United Wholesale Mortgage (UWM), the #1 overall mortgage lender, wholesale and purchase mortgage lender in the U.S., will announce its first quarter 2026 financial results on Wednesday, May 6, 2026. A press release with financial highlights will be available on the company’s investor relations website https://investors.uwm.com in the financials section. The company will also host a Q&am...

NEW YORK--(BUSINESS WIRE)--NYSE today reported short interest as of the close of business on the settlement date of April 15, 2026. SETTLEMENT DATE EXCHANGE TOTAL CURRENT SHORT INTEREST TOTAL PREVIOUS SHORT INTEREST (Revised) NUMBER of SECURITIES with a SHORT POSITION NUMBER of SECURITIES with a POSITION >= 5,000 SHARES 04/15/2026 NYSE 17,363,958,102 17,648,394,291 2,880 2,606 04/15/2026 NYSE ARCA 2,225,622,986 2,336,811,859 2,582 1,750 04/15/2026 NYSE AMERICAN 914,879,343 893,347,701 311 25...

NEW YORK--(BUSINESS WIRE)--KBRA assigns a long-term rating of AA+ to the State of Connecticut: General Obligation Bonds (2026 Series A); General Obligation Refunding Bonds (2026 Series B); and, Taxable General Obligation Bonds (2026 Series A). KBRA additionally affirms the long-term rating of AA+ for the State's outstanding General Obligation Bonds. The rating Outlook is Stable. Key Credit Considerations The rating actions reflect the following key credit considerations: Credit Positives State...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Orthofix Medical, Inc. (“Orthofix” or the “Company”) (NasdaqGS: OFIX).On September 12, 2023, the Company announced the appointment of an interim CEO, interim CFO, and interim CLO, effective immediately, following the “unanimous decision by the Board’s independent directors...

NEW YORK--(BUSINESS WIRE)--KBRA assigns a long-term rating of AA- to the Canutillo Independent School District (the District), Texas, Unlimited Tax School and Building and Refunding Bonds, Series 2026 (the 2026 Bonds). Concurrently, KBRA affirms the AA- rating for the District's outstanding unlimited tax bonds. The Outlook is Stable. Proceeds of the 2026 Bonds will finance the construction of school facilities, refinance certain outstanding Bonds of the District, and fund the costs of issuance....

INCHEON, Corea--(BUSINESS WIRE)--Samsung Epis Holdings (KRX: 0126Z0), società di investimento focalizzata sulle innovazioni nel settore biofarmaceutico e biotecnologico, oggi ha reso noti i risultati finanziari relativi al primo trimestre dell'esercizio 2026. "Nel corso del trimestre, Samsung Bioepis ha registrato una forte crescita in questo trimestre, trainata dal continuo slancio del portafoglio dei nostri biosimilari", è il commento di Kyung-Ah Kim, presidente e Chief Executive Officer (CEO...

INCHEON, Coreia--(BUSINESS WIRE)--A Samsung Epis Holdings (KRX: 0126Z0), uma empresa de investimentos dedicada a inovações em biofarmacêuticos e biotecnologia, anunciou hoje seus resultados financeiros para o primeiro trimestre do ano fiscal de 2026. “A Samsung Bioepis apresentou um crescimento sólido neste trimestre, impulsionado pelo contínuo avanço de nosso portfólio de biossimilares”, disse Kyung-Ah Kim, presidente e CEO da Samsung Epis Holdings. “Estamos fortalecendo ainda mais nossa posiç...

INCHEON, Korea--(BUSINESS WIRE)--Samsung Epis Holdings (KRX: 0126Z0), een investeringsmaatschappij die zich toelegt op innovaties in biofarmaceutica en biotechnologie, maakte vandaag de financiële resultaten bekend voor het eerste kwartaal van boekjaar 2026. “Dit kwartaal verwezenlijkte Samsung Bioepis een robuuste groei door toedoen van een verdergezet momentum in onze portfolio biosimilaire geneesmiddelen," verklaart Kyung-Ah Kim, voorzitter en CEO van Samsung Epis Holdings. “We werken aan ve...